BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Pharm Country

  Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering

  Record date established as February 14, 2018.

  February 7, 2018

   · 

  8 min read
• Drug Development

  Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

  Abeona plans to enroll a total of three patients in Cohort 1 (2E13 vg/kg) before dose-escalating to the Cohort 2 dose (5E13 vg/kg).

  February 7, 2018

   · 

  8 min read
• BioMidwest

  Medical College of Wisconsin Release: CAR-T Cell Immunotherapy Clinical Trial Cancer Patient in Remission; First-in-the-World Cancer Treatment Shows Promise

  Bret C., 52, of Appleton, Wis., is the first patient to participate in this novel clinical trial.

  February 7, 2018

   · 

  2 min read
• Drug Development

  Impel NeuroPharma Announces Positive Results of Phase I Clinical Trial of INP104 for Treatment of Acute Migraine Headache

  INP104 is a novel dihydroergotamine product dosed via Impel’s proprietary Precision Olfactory Delivery, or POD, intranasal delivery device.

  February 7, 2018

   · 

  3 min read
• Pharm Country

  Cagent Vascular Presents Positive Results from the PRELUDE Study at LINC 2018

  Dr. Andrew Holden (Auckland, New Zealand), Principal Investigator, presented 30-day and preliminary 6-month results using the FDA 510(k) cleared Serranator Alto PTA Serration Balloon Catheter at the Leipzig Interventional Course last week.

  February 7, 2018

   · 

  3 min read
• Business

  Advanced Proteome Therapeutics and ImmunoBiochem Corporation Enter Into a Collaboration and Option Agreement

  The companies will evaluate the prospect of combining ImmunoBiochem’s proprietary antibody and APC’s site-selective conjugation technology to produce ADCs with superior properties, targeting triple-negative breast cancer.

  February 7, 2018

   · 

  4 min read
• Business

  Dyadic International Announces Research and Development Collaboration to Produce An Active Ingredient in C1

  The deal will explore the potential of its C1 technology to produce an important active moiety with an integrated, global biotech company.

  February 7, 2018

   · 

  4 min read
• 

  Deals

  Coloplast Acquires IncoCare Gunhild Vieler GmbH for Undisclosed Sum

  IncoCare is a privately owned, German direct-to consumer homecare company with regional distribution of primarily continence supplies.

  February 7, 2018

   · 

  1 min read
• Business

  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast

  Management will host a conference call on that date at 10:00 a.m. EST to discuss these results and provide an update on the company.

  February 7, 2018

   · 

  1 min read
• Pluristem Issues Letter to Shareholders

  Co-CEOs, Zami Aberman and Yaky Yanay.issued the letter to shareholders.

  February 7, 2018

   · 

  9 min read